Vernal
keratoconjunctivitis differs from seasonal allergic conjunctivitis and perennial allergic conjunctivitis, because it is a condition mediated by Th2 lymphocytes.
Petitti et al., "Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal
keratoconjunctivitis," British Journal of Ophthalmology, vol.
Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic
keratoconjunctivitis in health care facilities.
A prospective, controlled clinical study was conducted to evaluate 62 consecutively enrolled patients that were admitted to the Ankara Ataturk Training and Research Hospital between July 2013 and September 2014 with suspected viral conjunctivitis (who had at least one of the following complaints and findings: hyperemia, lacrimation, foreign body sensation, discharge, burning, follicular conjunctivitis, conjunctival hemorrhages, membrane formation, eyelid swelling, or conjunctival hemorrhages) or
keratoconjunctivitis (those who had punctate corneal defects or subepithelial infiltrates in addition to viral conjunctivitis findings).
Potential adverse effects of eyelash extensions include ocular hyperemia,
keratoconjunctivitis, allergic blepharitis, and allergic contact dermatitis in the patient.
and millions of people worldwide contract preventable eye infections particularly a serious viral infection called Epidemic
Keratoconjunctivitis (EKC) at their local eye care clinic through inadequate or failed medical office sanitation.
Unrecognized ultraviolet induced
keratoconjunctivitis. Ann Emerg Med.
Vernal
keratoconjunctivitis (VKC) is a severe inflammatory disease that commonly manifests seasonally during childhood, whereas a perennial and persistent form of the disease is less frequent [1].
Since the early 2000s, microsporidial
keratoconjunctivitis has been increasingly reported, mostly in Singapore (8-10) and India (11), among healthy, immunocompetent persons.
Dry eyes, also known as
keratoconjunctivitis sicca (KCS), is an eye disorder that is most often caused by decreased tear production, but may also result from increased evaporation of the tear film due to abnormal tear composition.
announced today that it has entered into an exclusive license agreement with Dechra Pharmaceuticals PLC for the development and commercialization of SCY 641 for the treatment of canine
keratoconjunctivitis sicca (KCS).
An option in vernal
keratoconjunctivitis? Allergol Immunopathol (Madr).
